Table 2 Response to treatment

From: Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

 

Patients (n=41)

 

No.

%

Overall response

28

68

95% CI

53–80

Complete response

16

39

Partial response

12

29

Stable disease

5

12

Progressive disease

7

17

Nonassessable

1

3

Back to article page